Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
HERAMED LIMITED (HMD)ASX AI Signals has generated 2 signal(s) for HMD during the last 90 days, indicating Moderate trading activity
Latest HMD Signals | |
| 18/06/2026 | SELL |
| 22/04/2026 | BUY |
| 30/03/2026 | BUY |
HMD Share Price | |
| Current Price | $0.043 |
| 52 Week High | $0.050 |
| 52 Week Low: | $0.011 |
| Trading at (% of 52 Week High) | 86.00% |
HERAMED LIMITED (ASX: HMD) is a healthcare company that develops and distributes medical devices and pharmaceutical products. The company focuses on innovative health solutions, primarily targeting Asian markets. It aims to improve patient outcomes through advanced medical technology and pharmaceuticals.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for HERAMED LIMITED (HMD) is supported by current market signals indicating potential downside risk, but the relatively low stock price and limited available data suggest moderate uncertainty. Investors should consider volatility and lack of strong positive catalysts before making decisions.
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
HAIFA, Israel, JulyLatest HERAMED LIMITED(HMD) News
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial